We're excited to announce that 𝗥𝘂𝗯𝗶𝗰𝗼𝗻 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (www.rubicon.co.in), a leading specialty pharmaceutical company dedicated to developing differentiated high-quality products, will be attending CPHI 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰. As we continue to expand our portfolio and enhance our product offerings, we are keen to connect with reliable API suppliers who can support our mission to deliver quality pharmaceutical solutions. Our key interests include meeting trustworthy suppliers of general and cytotoxic APIs, as well as devices and specialty performance materials. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗢𝗳𝗳𝗲𝗿: 𝗖𝘂𝘁𝘁𝗶𝗻𝗴 𝗘𝗱𝗴𝗲 𝗙𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 | Leverage our advanced formulation technologies and industry knowledge 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 | Opportunities for long-term collaborations and mutually beneficial relationships 𝗚𝗹𝗼𝗯𝗮𝗹 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗮𝗰𝗵 | Tap into our extensive distribution network and international presence 𝗟𝗲𝘁’𝘀 𝗺𝗲𝗲𝘁 𝗮𝘁 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰! We would be delighted to explore potential synergies and discuss how we can work together to achieve our shared goals. 𝗙𝗼𝗿 𝗔𝗣𝗜 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀, please drop a line to Nikita Thakkar- Mawani at [email protected] or Karthikeyan Dhandapani at [email protected] Looking forward to meeting you at CPHI-Milan! 𝗗𝗮𝘁𝗲: October 8-10, 2024 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Booth No. 16A080, CPHI Milan, Fiera Milano, Italy #CPHIMilan #Pharmaceuticals #GenericDrugs #PartnerWithUs #HighQuality #Distribution #StrategicPartnerships #Co-development #JointVenture
Rubicon Research Limited
Pharmaceutical Manufacturing
Thane , Maharashtra 38,668 followers
About us
Rubicon Research Limited is an IP-led, pharmaceutical company focused on developing value added products for the pharmaceutical industry as well as developing a portfolio of generic prescription and OTC products across a range of therapeutic categories. We leverage our proprietary technologies and specialized formulation development skills to provide solutions to complex delivery challenges. Our portfolio spans multiple dosage forms, including oral solids, oral liquids, ophthalmic, nasal, injectable, topical, drug device combinations and fixed-dose combinations. We have 50 patents in drug delivery technologies, with over 28 approved products in the US. We also have 70 products in development and 10 products under review with the US FDA. Our state-of-the-art R&D center in Thane, Maharashtra, is built to GMP standards and equips us to carry out complete: • Oral solid dosage form development from pre-formulation studies up to pilot scale in a single facility • Oral liquid dosage form development suite up to pilot scale • Topical dosage form development suite up to pilot scale • Sterile dosage form development including injectable and ophthalmic dosages • Dedicated containment suite for development of highly potent products including hormonal products and oncology products In 2019, we acquired Impopharma Canada Ltd, establishing Rubicon Research Canada Ltd. This facility supports the development of pulmonary and nasal drug delivery systems and ophthalmic, otic, and dermal products. In 2020, we launched Rubicon Consumer Healthcare, a subsidiary that develops healthcare and personal wellness solutions for the Indian market. In 2020 we also launched Rubicon Academy, a learning platform for pharmaceutical professionals and students. Rubicon Research operates out of 4 locations—the corporate HQ and R&D center in Thane, India, the R&D center in Concord, Canada, the manufacturing site in Ambernath, India, and business development and regulatory office in Plainsboro, US.
- Website
-
https://www.rubicon.co.in
External link for Rubicon Research Limited
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Thane , Maharashtra
- Type
- Privately Held
- Specialties
- Formulation Development, ANDAs, 505(b2), OTC Development, Analytical Method Development, Life Cycle Management Options, USFDA Approved GMP Site, Drug Delivery Technologies, and Clinical Trial Supplies
Locations
Employees at Rubicon Research Limited
Updates
-
𝗠𝗲𝗲𝘁 𝘂𝘀 𝗮𝘁 𝗖𝗣𝗛𝗜-𝗠𝗶𝗹𝗮𝗻! Rubicon Research Limited (www.rubicon.co.in) is actively pursuing strategic partnerships and business development opportunities at CPHI Worldwide to expand into new markets. We are particularly seeking strategic partnerships, co-development collaborations, and joint ventures to accelerate market entry and harness complementary strengths. We welcome discussions on country specific products and business models to craft customized strategic partnerships and leverage mutual expertise. We look forward to meeting like-minded collaborators who share our commitment to innovation and delivering high-quality healthcare solutions. For emerging markets, please drop a line to MANOJ AWASTHI at [email protected] or Supriya Sansare at [email protected] and we will get back to you. Looking forward to meeting you at CPHI-Milan! 𝗗𝗮𝘁𝗲: October 8-10, 2024 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Booth No. 16A080, CPHI Milan, Fiera Milano, Italy #CPHIMilan #Pharmaceuticals #GenericDrugs #PartnerWithUs #HighQuality #Distribution #StrategicPartnerships #Co-development #JointVenture
-
Rubicon Research Limited reposted this
𝗔𝗱𝘃𝗮𝗚𝗲𝗻 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹𝗹𝘆 𝘄𝗿𝗮𝗽𝘀 𝘂𝗽 𝗡𝗔𝗖𝗗𝗦 𝗧𝗦𝗘 𝘃𝗶𝘀𝗶𝘁 AdvaGen Pharma is pleased to announce the successful conclusion of our presence at the National Association of Chain Drug Stores (NACDS) Total Store Expo in Boston. We extend our sincere gratitude to our partners and customers for the productive meetings and meaningful engagements throughout the event – your collaboration is invaluable. AdvaGen is your reliable partner for high-quality and affordable generic drugs in the US. #NACDSTSE #Pharmaceuticals #GenericDrugs #Healthcare #AffordableCare
-
𝗪𝗶𝘀𝗵𝗶𝗻𝗴 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲 𝗮 𝗷𝗼𝘆𝗳𝘂𝗹 & 𝗵𝗲𝗮𝗹𝘁𝗵𝘆 𝗥𝗮𝗸𝘀𝗵𝗮𝗯𝗮𝗻𝗱𝗵𝗮𝗻! Today, we celebrate the bonds of love and protection that unite us. Just as siblings stand by each other, we at Rubicon Research value the trust and collaboration that strengthen our relationships. #Rakshabandhan #Togetherness #rakhi24
-
We look forward to engaging with industry professionals. Join us and learn more about how we can be your reliable partner for high-quality & affordable generic drugs in the US…
𝗝𝗼𝗶𝗻 𝗔𝗱𝘃𝗮𝗚𝗲𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗳𝗿𝗼𝗺 𝘁𝗼𝗱𝗮𝘆 𝗮𝘁 𝗡𝗔𝗖𝗗𝗦 𝗧𝗦𝗘 𝟮𝟬𝟮𝟰! AdvaGen Pharma is excited to invite you to meet our top executives at the NACDS Total Store Expo, taking place from today till August 19, 2024. Visit us at Booth No. 461 at the Boston Convention and Exhibition Center to discover how we can be your reliable partner for high-quality & affordable generic drugs in the US. We look forward to connecting with potential partners and showcasing our proven capabilities and commitment to excellence. Choose AdvaGen to ensure no prescription goes unfulfilled! 𝗗𝗮𝘁𝗲: August 17-19, 2024 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Booth No. 461, National Association of Chain Drug Stores (NACDS) TSE, Boston Convention and Exhibition Centre #NACDSTSE #Pharmaceuticals #GenericDrugs #PartnerWithUs #HighQuality
-
𝗪𝗲 𝘄𝗶𝘀𝗵 𝘆𝗼𝘂 𝗮 𝗵𝗮𝗽𝗽𝘆 & 𝗵𝗲𝗮𝗹𝘁𝗵𝘆 𝗜𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝗰𝗲 𝗗𝗮𝘆! Rubiconians kicked off Independence Day celebrations with a proud rendition of the national anthem. This was followed by a popular game where participants had to draw something special from their state on balloons! Delicious snacks completed the festivities with each employee also getting a sapling as a take-back gift. A big thank-you to our amazing Rubiconians for making this celebration truly memorable across our Thane, Ambernath and Satara offices! Together, we continue to uphold the values of freedom, diversity, and excellence that define us. #IndependenceDay #Unity #ProudToBeIndian #August15 #JaiHind
-
Rubicon Research Limited reposted this
𝗝𝗼𝗶𝗻 𝗔𝗱𝘃𝗮𝗚𝗲𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗮𝘁 𝗡𝗔𝗖𝗗𝗦 𝗧𝗦𝗘 𝟮𝟬𝟮𝟰! AdvaGen Pharma is excited to invite you to meet our top executives at the NACDS Total Store Expo, taking place from August 17-19, 2024. Visit us at Booth No. 461 at the Boston Convention and Exhibition Center to discover how we can be your reliable partner for high-quality & affordable generic drugs in the US. We look forward to connecting with potential partners and showcasing our proven capabilities and commitment to excellence. Choose AdvaGen to ensure no prescription goes unfulfilled! 𝗗𝗮𝘁𝗲: August 17-19, 2024 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Booth No. 461, National Association of Chain Drug Stores (NACDS) TSE, Boston Convention and Exhibition Centre #NACDSTSE #Pharmaceuticals #GenericDrugs #PartnerWithUs #HighQuality
-
Be there!
𝗝𝗼𝗶𝗻 𝗔𝗱𝘃𝗮𝗚𝗲𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗮𝘁 𝗡𝗔𝗖𝗗𝗦 𝗧𝗦𝗘 𝟮𝟬𝟮𝟰! AdvaGen Pharma is excited to invite you to meet our top executives at the NACDS Total Store Expo, taking place from August 17-19, 2024. Visit us at Booth No. 461 at the Boston Convention and Exhibition Center to discover how we can be your reliable partner for high-quality & affordable generic drugs in the US. We look forward to connecting with potential partners and showcasing our proven capabilities and commitment to excellence. Choose AdvaGen to ensure no prescription goes unfulfilled! 𝗗𝗮𝘁𝗲: August 17-19, 2024 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Booth No. 461, National Association of Chain Drug Stores (NACDS) TSE, Boston Convention and Exhibition Centre #NACDSTSE #Pharmaceuticals #GenericDrugs #PartnerWithUs #HighQuality #AffordableCare
-
Best wishes to the Indian Olympics team as they embark on their journey to greatness. Your dedication, hard work, and spirit inspire us all. We're cheering you on and are proud of your commitment to excellence and good health. 𝑮𝒐 𝑻𝒆𝒂𝒎 𝑰𝒏𝒅𝒊𝒂!!! #Olympics #Paris2024 #GoForGold #Sportsmanship #ChakDeIndia
-
Rubicon Research was thrilled to host a study tour at our Ambernath manufacturing facility for 32 enthusiastic B.Pharm. students from Dr. L. H. Hiranandani College of Pharmacy (Ulhasnagar) and SVKM's Institute of Pharmacy, Dhule. The students had a unique opportunity to interact with industry veterans and dive into the intricacies of pharmaceutical operations – including manufacturing, packaging, and warehousing – for our entire range of products. In particular, they appreciated the Q&A session of our tailor-made tour, which emphasised hands-on roles in the industry rather than confining themselves to desk jobs. Here's to inspiring the next generation of pharma professionals! #RubiconResearch #PharmaTour #FutureLeaders #Pharma #CareerGrowth